0000891293-15-000055.txt : 20151023 0000891293-15-000055.hdr.sgml : 20151023 20151023174249 ACCESSION NUMBER: 0000891293-15-000055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151022 FILED AS OF DATE: 20151023 DATE AS OF CHANGE: 20151023 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CTI BIOPHARMA CORP CENTRAL INDEX KEY: 0000891293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911533912 STATE OF INCORPORATION: WA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: 2062827100 MAIL ADDRESS: STREET 1: 3101 WESTERN AVENUE STREET 2: SUITE 600 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: CELL THERAPEUTICS INC DATE OF NAME CHANGE: 19960321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIANCO LOUIS A CENTRAL INDEX KEY: 0001204260 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12465 FILM NUMBER: 151173575 MAIL ADDRESS: STREET 1: 501 ELLIOT AVENUE WEST STREET 2: SUITE 400 CITY: SEATTLE STATE: WA ZIP: 98119 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-10-22 0 0000891293 CTI BIOPHARMA CORP ctic 0001204260 BIANCO LOUIS A 3101 WESTERN AVE SUITE 600 SEATTLE WA 98121 0 1 0 0 EVP, Finance & Administration Common Stock 2015-10-22 4 S 0 10000 1.58 D 931347 D Common Stock 37 I Trust for children The sale was effected pursuant to a Rule 10b5-1 trading plan. Louis A. Bianco 2015-10-23